Search companies or stocks...
Centessa Pharmaceuticals plc (CNTA) intrinsic value snapshot: the calculated gap versus modeled fair value is 8405.5% at a market price of $40.50. Unlock the dollar fair value estimate for Centessa Pharmaceuticals plc with Tickerplace Pro.
Intrinsic Value (Fair Value): Unlock fair value
Fair value gap: -8405.5%
Margin of Safety: Unlock fair value
Current Price: $40.50
Gap size: Large gap
How we calculate fair value: We combine DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models to estimate intrinsic value. This figure is for information only - not investment advice - and assumptions may not reflect actual market conditions. We encourage doing your own research or speaking with a financial advisor before making investment decisions.
Search our company database (same as the site header), pick a match, or type a ticker to open its intrinsic value analysis.
The fair-value gap for Centessa Pharmaceuticals plc (CNTA) is summarised in the snapshot above. This section explains the method: we compare the live market price with modeled fair value using DCF, P/E Multiple, and P/S Multiple approaches. Assumptions can change with new earnings, growth, and discount-rate inputs, so treat the figures as a research aid rather than a buy or sell signal. Tickerplace Pro unlocks the dollar fair value used in that comparison.
Use this section for context around the gap. The free snapshot above already shows the percentage difference and market price; the dollar intrinsic value stays behind Tickerplace Pro. Compare CNTA with related intrinsic-value pages listed below (APGE, AAPG, C, and more) to see how peers are framed on the same models.
Tickerplace calculates a modeled intrinsic value estimate for Centessa Pharmaceuticals plc (CNTA) using DCF, P/E Multiple, and P/S Multiple models based on projected cash flows, growth, and a discount rate. Sign in to Tickerplace Pro to view the full dollar estimate.
CNTA’s current market price is $40.50, a difference of 8405.5%. This is a model output from DCF, P/E, and P/S, not a buy or sell conclusion.
Tickerplace calculates CNTA's intrinsic value using Discounted Cash Flow (DCF), P/E Multiple, and P/S Multiple models. We project future cash flows, apply a discount rate that reflects investment risk, and compare the resulting fair value estimate to the current market price.
Peers for CNTA: open their intrinsic value pages.
